2019
9: Randomized controlled trial of n-acetylcysteine to prevent adverse neonatal outcome in pregnancies with intra-amniotic infection/inflammation
Buhimschi C, Bahtiyar M, Abdelghany O, Schneider L, Abdel-Raqez S, Dulay A, Lipkind H, Lopez E, Zhao G, Rogers L, Bhandari V, Buhimschi I. 9: Randomized controlled trial of n-acetylcysteine to prevent adverse neonatal outcome in pregnancies with intra-amniotic infection/inflammation. American Journal Of Obstetrics And Gynecology 2019, 220: s9. DOI: 10.1016/j.ajog.2018.11.011.Peer-Reviewed Original Research
2015
417: Neonates exposed to inflammation in-utero carry a spectrum of potent inflammatory and oxidant circulating molecules, that can be potentially reversed by N-acetylcysteine (NAC) and ethylpyruvate (EP)
Buhimschi I, Li M, Zhao G, Bahtiyar M, Cackovic M, Madri J, Bhandari V, Buhimschi C. 417: Neonates exposed to inflammation in-utero carry a spectrum of potent inflammatory and oxidant circulating molecules, that can be potentially reversed by N-acetylcysteine (NAC) and ethylpyruvate (EP). American Journal Of Obstetrics And Gynecology 2015, 212: s217. DOI: 10.1016/j.ajog.2014.10.463.Peer-Reviewed Original Research